rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jeffrey Bluestone

Director

Company insider

Files Form 4 as: Director, Gilead Sciences; Director, Provention Bio.

Every Form 4 they filed

In numbers

Trades disclosed
73
Buys
0
Sells
6
Bought
$0
Sold
$4.6M
Companies
2
Companies where not an officer
2
First trade
27 Mar 2019
Last trade
20 Aug 2026
Last filed
21 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
GILD Gilead SciencesDirector · Biotechnology · last 20 Aug 20260 buys · 5 sells
Provention BioDirector · last 17 May 20220 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$79K1,165 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$49K335 at $146.26filing
20 Aug 2026filed 21 Aug 2026GILD Gilead Sciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,665 at $0.00filing
20 Aug 2026filed 21 Aug 2026GILD Gilead Sciencesoption or derivative · BiotechnologySEC FORM 4 Code M—335 at $0.00filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$167K1,165 at $143.75filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$122K1,816 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead Sciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,665 at $0.00filing
20 Aug 2026filed 21 Aug 2026GILD Gilead Sciencesoption or derivative · BiotechnologySEC FORM 4 Code M—335 at $0.00filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$263K1,816 at $144.92filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$112K1,658 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$242K1,658 at $145.73filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$1,75426 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$3,80526 at $146.36filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$21K335 at $61.35filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$79K1,165 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$167K1,165 at $143.75filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$122K1,816 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$263K1,816 at $144.92filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Code M$112K1,658 at $67.45filing
20 Aug 2026filed 21 Aug 2026GILD Gilead SciencesBiotechnologySEC FORM 4 Sold$242K1,658 at $145.73filing

Sectors

Health Care5
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Johanna MercierChief Comm & Corp Aff Officer · Chief Comm & Corp Aff Officer at Gilead Sciences, filing Form 4 there in the last year
Andrew D. DickinsonChief Financial Officer · Chief Financial Officer at Gilead Sciences, filing Form 4 there in the last year
Daniel Patrick O'DayChairman & CEO · Chairman & CEO at Gilead Sciences, filing Form 4 there in the last year
Erin BurkhartSVP, Controllership · SVP, Controllership at Gilead Sciences, filing Form 4 there in the last year
Wettan Keeley M. CainEVP Gen Counsel, Legal & Comp · EVP Gen Counsel, Legal & Comp at Gilead Sciences, filing Form 4 there in the last year
Anthony WeltersDirector · Also traded GILD in the last 90 days